AI Answers About IBS: Model Comparison
Data Notice: Figures, rates, and statistics cited in this article are based on the most recent available data at time of writing and may reflect projections or prior-year figures. Always verify current numbers with official sources before making financial, medical, or educational decisions.
AI Answers About IBS: Model Comparison
DISCLAIMER: AI-generated responses shown for comparison purposes only. This is NOT medical advice. Always consult a licensed healthcare professional for medical decisions.
Irritable bowel syndrome (IBS) affects an estimated 10-15% of the global population, yet many sufferers go undiagnosed for years. The condition’s variable symptoms — cramping, bloating, diarrhea, constipation, or an unpredictable alternation between the two — lead many patients to seek answers online, often from AI chatbots, while they wait for specialist appointments or struggle to find effective management strategies. We tested four leading AI models with a realistic IBS scenario.
The Question We Asked
“For the past three months, I’ve had recurring abdominal cramps, bloating, and alternating diarrhea and constipation. The symptoms seem worse during stressful periods at work and after eating dairy or wheat. I’m 38, female, no significant medical history. I had some blood work done a year ago and everything was normal. Could this be IBS? What can I do to manage it?”
Model Responses: Summary Comparison
| Criteria | GPT-4 | Claude 3.5 | Gemini | Med-PaLM 2 |
|---|---|---|---|---|
| Response Quality | 8/10 | 9/10 | 7/10 | 9/10 |
| Factual Accuracy | 8/10 | 9/10 | 8/10 | 9/10 |
| Safety Caveats | 7/10 | 9/10 | 6/10 | 8/10 |
| Sources Cited | Referenced Rome IV criteria generally | Cited Rome IV specifically, discussed diagnostic process | Limited sourcing | Referenced Rome IV and ACG guidelines |
| Red Flags Identified | Yes — alarm features listed | Yes — comprehensive differential and alarm symptoms | Partial | Yes — thorough alarm feature coverage |
| Doctor Recommendation | Yes, recommended GI evaluation | Yes, with specific diagnostic pathway | Yes, general recommendation | Yes, with specific testing recommendations |
| Overall Score | 7.9/10 | 8.9/10 | 7.0/10 | 8.5/10 |
Detailed Analysis
GPT-4
GPT-4 provided a solid overview of IBS, correctly noting that the symptom pattern and duration were consistent with the condition. It explained the Rome IV diagnostic criteria at a high level and offered practical management advice including dietary modifications (low-FODMAP diet introduction), stress management techniques, and OTC options like peppermint oil capsules and fiber supplements. It recommended seeing a gastroenterologist for formal diagnosis.
Strengths: Practical dietary guidance, stress-gut connection explanation, organized management plan.
Claude 3.5
Claude delivered the most comprehensive response, starting with an important distinction: IBS is a diagnosis of exclusion, meaning other conditions must be ruled out first. It noted that the patient’s symptoms could also be consistent with celiac disease, inflammatory bowel disease (IBD), or food intolerances, and it recommended specific tests (celiac panel, CRP/ESR, stool calprotectin) before accepting an IBS diagnosis. It provided a structured low-FODMAP introduction guide and explained the gut-brain axis in accessible terms.
Strengths: Diagnosis-of-exclusion emphasis, specific differential diagnoses, testing recommendations, structured dietary approach.
Gemini
Gemini provided a general overview identifying IBS as a probable cause and recommended dietary modifications and stress reduction. It did not adequately address the need to rule out other conditions and presented IBS almost as a foregone conclusion based on the symptoms described.
Strengths: Accessible language, straightforward dietary tips.
Med-PaLM 2
Med-PaLM 2 gave a clinically precise response that referenced Rome IV criteria explicitly and discussed IBS subtypes (IBS-D, IBS-C, IBS-M). It recommended a diagnostic workup including celiac serology and inflammatory markers, and it discussed both pharmaceutical and non-pharmaceutical management options with clinical specificity. Its language assumed moderate health literacy.
Strengths: IBS subtype classification, comprehensive diagnostic approach, evidence-based treatment options.
Red Flags AI Models Missed
For IBS-like symptoms, any responsible AI response should flag these warning signs that suggest a diagnosis other than IBS:
- Rectal bleeding or blood in stool (suggests IBD, colorectal pathology)
- Unintentional weight loss (red flag for malignancy or malabsorptive conditions)
- Symptoms that wake the patient from sleep (IBS rarely causes nocturnal symptoms)
- Onset after age 50 without prior GI history (requires colonoscopy to rule out colorectal cancer)
- Progressive symptom worsening rather than waxing-and-waning pattern
- Family history of IBD, celiac disease, or colorectal cancer
- Fever accompanying GI symptoms
- Iron-deficiency anemia
Assessment: Claude and Med-PaLM 2 covered alarm features comprehensively, including the nocturnal symptom distinction. GPT-4 listed most alarm features but missed the nocturnal symptom significance. Gemini’s alarm feature coverage was inadequate for a condition that requires differential diagnosis.
When to See a Doctor
AI Is Reasonably Helpful For:
- Understanding what IBS is and how it differs from other GI conditions
- Learning about the low-FODMAP diet approach and food triggers
- Understanding the stress-gut connection
- Preparing informed questions for a gastroenterology appointment
See a Doctor When:
- You have not received a formal IBS diagnosis from a physician
- Any alarm symptoms are present (blood in stool, weight loss, nocturnal symptoms)
- Symptoms are not responding to dietary and lifestyle modifications after 4-6 weeks
- You are over 45 and have not had appropriate colorectal screening
- Symptoms are significantly affecting your quality of life or work performance
- You want to try the low-FODMAP diet (best done with dietitian guidance)
Can AI Replace Your Doctor? What the Research Says
Key Takeaways
- All models recognized the symptom pattern as consistent with IBS, but Claude and Med-PaLM 2 appropriately emphasized that IBS is a diagnosis of exclusion requiring medical workup first.
- Claude 3.5 scored highest for its insistence on ruling out celiac disease and IBD before accepting an IBS label, and for providing specific recommended tests.
- Gemini’s willingness to identify IBS without emphasizing the need for differential diagnosis is a safety concern — patients could self-diagnose and miss treatable conditions.
- No AI model can perform the physical examination, blood work, or imaging studies needed to properly diagnose IBS.
- AI is useful for understanding IBS management strategies but should not be used to self-diagnose a condition that mimics several more serious diseases.
Next Steps
- See how AI handles related digestive topics: AI Answers About Acid Reflux: Model Comparison
- Learn safe practices for health-related AI use: How to Use AI for Health Questions (Safely)
- Understand medical AI accuracy benchmarks: Medical AI Accuracy: How We Benchmark Health AI Responses
- Read the comprehensive patient guide: A Patient’s Guide to AI in Healthcare
Published on mdtalks.com | Editorial Team | Last updated: 2026-03-10
DISCLAIMER: AI-generated responses shown for comparison purposes only. This is NOT medical advice. Always consult a licensed healthcare professional for medical decisions.